Evidence map›Paper›PMID 37505316›Full record

ArticleCancer causes & control : CCC2023

A community engagement training program for basic and translational cancer researchers.

Ronald C Chen, Hope Krebill, Teri Kennedy, Sara Douglas, Kristi L Neufeld, Danny R Welch, Cheryl Jernigan, Kim S Kimminau, Kristy Johnston, Jane Hughes and 1 more

Open access · greenAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ronald C ChenUniversity of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA. Rchen2@kumc.edu.
Hope KrebillUniversity of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.
Teri KennedyOffice of Interprofessional Practice, Education, Policy, & Research, University of Kansas School of Nursing, University of Kansas Medical Center, Kansas City, KS, USA.
Sara DouglasPatient and Investigator Voices Organizing Together, University of Kansas Cancer Center, Fairway, KS, USA.
Kristi L NeufeldUniversity of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.
Danny R WelchUniversity of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.
Cheryl JerniganPatient and Investigator Voices Organizing Together, University of Kansas Cancer Center, Fairway, KS, USA.
Kim S KimminauPatient and Investigator Voices Organizing Together, University of Kansas Cancer Center, Fairway, KS, USA.
Kristy JohnstonCenter for Interprofessional Practice, Education, and Research , University of Kansas Medical Center, Kansas City, KS, USA.
Jane HughesOrganizational Development Office, University of Kansas Medical Center, Kansas City, KS, USA.
Roy A JensenUniversity of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, KS, USA.
The University of Kansas Cancer Center · USUniversity of Kansas Medical Center · USTogether · US

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ROY A. JENSEN · 2012 to 2026
$40.1M
NCI NIH HHS P30 CA168524NIH HHS P30CA168524-09S4
6 · The paper itself

Abstract

purposeThere is an increasing awareness of the importance of patient engagement in cancer research, but many basic and translational researchers have never been trained to do so. To address this unmet need, a 1-year patient engagement training program for researchers was developed.

methodsEleven researchers and eleven paired research advocates participated. This program, designed for virtual delivery, included 3 didactic modules focused on (1) Community Outreach and Engagement principles and methods, (2) Communication skills, and (3) Team Science. This was followed by longitudinal projects to be completed by the researcher/advocate pairs, including learning about the research project, and co-authoring abstracts, manuscripts and grant proposals. Monthly group meetings allowed pairs to share their experiences. The program culminated in the pairs creating and presenting oral abstracts for the University of Kansas Cancer Center's Annual Research Symposium.

resultsAll participants indicated that the modules had a positive impact on their ability to collaborate in research. Both researcher self-evaluations and patient advocate evaluations of their researcher partner showed an improvement in researcher communication competency. Results from the Patient Engagement in Research Scale showed that advocates were highly engaged. Within 1 year after program completion, participating pairs have completed four abstracts and 9 grant proposals.

conclusionThe program will be modified based on participant feedback, and can be adapted for future cohorts if an increased number of sessions per month and shortened program duration are desired. The program's virtual format allows scalability across institutions to potentially benefit large cohorts of researchers.

Indexed as

NeoplasmsResearch PersonnelCommunity-Institutional RelationsHumansResearch DesignCancerCommunity outreach and engagementPatient research advocateTraining program

Identifiers

PMID37505316
PMCPMC10902867
OpenAlexW4385330299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.